SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently seeing heightened retail engagement and bullish sentiment, with community members actively discussing potential price reversals and technical patterns. Traders are heavily debating the sustainability of these moves, while long-term holders continue to emphasize ecosystem developments and burn mechanisms as drivers for future growth.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum Inc. is experiencing heightened investor interest and volatility following news that the company secured a significant grant from the National Science Foundation, alongside broader optimism driven by executive actions establishing quantum computing as a national strategic priority. The community is actively debating the stock's future, weighing potential commercialization milestones against concerns regarding valuation, stock dilution, and market manipulation.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending as investors monitor the final legal outcome regarding Medicare bundling for Xphozah, while actively discussing the potential for a rerating once the company achieves sustained profitability. The community remains focused on robust Ibsrela sales momentum, upcoming clinical trial readouts, and speculation regarding a potential buyout.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as investors focus on the company's progress with its NXC-201 CAR-T therapy for AL amyloidosis, specifically anticipating upcoming trial data and a potential BLA submission. The community is actively discussing the company's strong institutional backing and the strategic implications of new leadership hires as they navigate the path toward clinical milestones.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility and social media attention as investors debate its potential for a short squeeze, fueled by high short interest and anticipation surrounding upcoming earnings. The community remains deeply divided between those betting on long-term growth and AI-driven expansion and skeptics who view recent price action as a broken IPO setup designed to benefit insiders.

GraniteShares ETF Trust - GraniteShares 2x Long MU Daily ETF

GraniteShares 2x Long MU Daily ETF

MULL is trending as investors react to volatility in the memory sector, with the community actively debating the risks of leveraged decay versus the potential for rapid gains as Micron continues its aggressive AI-driven growth trajectory. Discussions center on strategic scaling and technical entry points, as traders navigate the product's high sensitivity to Micron's performance.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

Telus is capturing investor attention as the community actively debates whether the company's dividend remains sustainable amid heavy infrastructure investments and a shifting telecom landscape. While some investors see a long-term value opportunity in its diversified growth strategy and AI expansion, others express frustration over recent stock performance and lingering concerns regarding debt levels and competitive pressures.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is capturing market attention as the company navigates strategic restructuring and board appointments following a significant stake from Elliott Investment Management, while simultaneously leveraging strong procedure demand and new product pipeline momentum. Investors are actively debating the company's long-term growth potential and dividend stability as it balances ongoing innovation in medical devices with broader sector-wide rotation trends.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust is capturing investor attention as the broader crypto market navigates high-stakes regulatory developments, including the Digital Asset Market CLARITY Act. Community discourse remains heavily focused on institutional inflows and Bitcoin's potential to serve as a macro hedge, despite ongoing debates regarding price volatility and the long-term impact of ETF flows.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing intense community speculation as investors anticipate a pivotal Phase 3 IZAR-1 readout for its lead drug, sonelokimab, which many view as a potential blockbuster for psoriatic arthritis and hidradenitis suppurativa. Discussion is heavily focused on potential M&A activity, with retail investors and institutional interest centered on the stock's undervaluation relative to competitive trial results and the possibility of a lucrative buyout by major pharmaceutical players.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

OVTIOmniVision Technologies Inc.

Latest OVTI News